?Chinese-made Surgical Robots Gain International Footprint?

At the 91st China International Medical Equipment (Spring) Exposition, the MicroPort Group exhibited its cutting-edge innovations, highlighting the "TuMai" multi-port laparoscopic surgical robot, model MT-4000.
After 11 years of research and iterative development, this robot boasts multiple upgrades, including a full-phase fluorescence imaging system for enhanced tumor visualization, 19 upgraded software for a superior operational experience, and compatibility with more than 40 high-dexterity, long-lasting surgical instruments, significantly reducing the cost of robotic surgery.
MicroPort Robotics has achieved significant progress in core robotic technology, 5G remote surgery, and AI, with its products entering nearly 30 countries in Europe, America, and along the Belt and Road, pioneering innovative paths for global surgical robot development and offering personalized configurations tailored to the needs of different medical institutions. The "Intelligent Surgery Comprehensive Solution Demonstration Area" attracted many domestic and foreign experts for trials, experiences, and cooperation negotiations, laying the foundation for the further promotion and application of domestic surgical robots.
?Launch of Domestic Medical-Grade Hearing Aids?

At the exposition, uOrigin's hearing aid series, u12 Lite, debuted on e-commerce platforms, targeting imported high-end hearing aids priced at ten thousand yuan with a price tag of just over two thousand yuan. Leveraging self-developed chips and an original Chinese hearing formula, this hearing aid excels in noisy environments such as kitchens, hospitals, traffic, and dining settings. Additionally, uOrigin, relying on its certified professional fitting specialists and auditory care teams, introduced a medical-grade hearing rehabilitation platform that integrates online and offline services, aiming to bridge the "last mile" in hearing health services.
A subsidiary of uOrigin, Micro-Electronics, signed strategic cooperation agreements with Tmall Health and JD Health, aiming to fully integrate resources and synergize their respective advantages to jointly build a new medical-grade hearing rehabilitation ecosystem combining "medical-grade products + medical-grade services." "Online channels are crucial for domestic hearing aids to reach thousands of households. We hope to collaborate with leading internet e-commerce platforms to provide convenient and professional medical-grade products and services to hearing-impaired individuals across broader regions," said Yu Yehueng, Senior Vice President of uOrigin.
The overall performance indicators of the uOrigin series meet international first-class standards, with some performance indicators, such as AI noise reduction and source-based howling suppression, leading globally. Equipped with the industry's first Chinese hearing platform, tailored to the characteristics of Chinese speech, focusing on tone, mid-to-high-frequency speech, and syllable-initial consonants, it features deeply customized Chinese speech enhancement algorithms and Chinese hearing formulas, enabling Chinese hearing-impaired individuals to rebuild their native hearing and enhancing their listening clarity, speech intelligibility, and comfort.
?Treating Tumors and Other Lesions with Ultrasound Ablation?

"Non-invasive focused ultrasound technology can theoretically treat over 180 diseases, but currently, only 32 indication treatment systems have been developed globally, with only 1,200 hospitals worldwide equipped with this technology, leaving vast potential to be explored," said Zhu Weizhen, CEO of Zhonghui Medical, at the high-end forum of the China International Medical Equipment (Spring) Exposition. The principle of non-invasive focused ultrasound technology involves generating high temperatures in specific areas of the human body to ablate tumors and other lesions. This non-invasive treatment has been used for conditions such as uterine fibroids, prostate cancer, liver cancer, and breast cancer, offering advantages such as rapid patient recovery, no hospitalization required, and no radiation.
Zhonghui Medical has established a long-term collaboration with Professor Chen Yazhu's team at the Chinese Academy of Engineering and the Honorary Dean of the School of Biomedical Engineering at Shanghai Jiao Tong University, along with multiple tertiary hospitals, forming an industry-academia-research-medicine alliance with over 50 patents applied, covering core modules of the ultrasound system. In June of last year, this Shanghai-based enterprise developed China's first phased array focused ultrasound tumor treatment system, approved by the National Medical Products Administration for marketing, marking a milestone in this technological field.
Leveraging 144 electronic phased array elements and an intelligent operating platform, this equipment achieves sub-millimeter treatment accuracy, enhancing treatment efficiency by over 50% compared to traditional mechanical focusing technology. Its accompanying 5G remote treatment system facilitates the implementation of tiered diagnosis and treatment, enabling patients in remote areas to access high-end medical resources.
To expand the clinical application of non-invasive focused ultrasound technology, Zhonghui Medical is developing a non-invasive focused ultrasound treatment robot. The company has built an innovative platform integrating "ultrasound + robot + AI," incorporating aerospace-grade control technology and intelligent navigation systems. The robot incubated on this platform has passed multiple clinical validations, with its modular expansion architecture adaptable to over 10 indications, including breast cancer, thyroid cancer, and pancreatic cancer, and plans to expand into emerging fields such as aesthetic medicine and veterinary medicine. "We hope this platform can be adapted to more indications, allowing non-invasive ultrasound technology to reshape the medical ecology," said Zhu Weizhen.

Shenzhen Yujiaxin Tech. Co., Ltd. specializes in custom manufacturing of high-precision and complex medical device components and surgical instrument parts from provided drawings.